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Abstract 
Introduction: The National Central Cancer Registry (NCCR) of China collected population-based cancer registration 
data from all cancer registries in China. This study aimed to compile national cancer incidences and mortalities in 2011 
and estimate cancer incident new cases and cancer deaths.
Methods: In 2014, there were 234 cancer registries that submitted records of new cancer cases and cancer deaths 
that occurred in 2011 to the NCCR. All datasets were evaluated based on the criteria of data quality of the NCCR. The 
data of 177 registries was of sufficient quality and was compiled to evaluate cancer statistics in 2011. The pooled 
data were stratified by area, sex, age group, and cancer type. Cancer incident cases and deaths were estimated using 
age-standardized rates (ASR) and the Chinese population. All incidences and mortalities were age-standardized to the 
2000 Chinese standard population and Segi’s population.
Results: The estimates of new cancer incident cases and cancer deaths were 3,372,175 and 2,113,048 in 2011, 
respectively. The crude incidence was 250.28/1,00,000 (277.77/1,00,000 for males and 221.37/1,00,000 for females). The 
ASRs of incidence by the Chinese standard population (ASRIC) and by the world standard population (ASRIW) were 
186.34/1,00,000 and 182.76/1,00,000, respectively, with a cumulative incidence (0–74 years old) of 21.20%. Cancers of 
the lung, female breast, stomach, liver, colorectum, esophagus, cervix, uterus, prostate, and ovary were the most com-
mon cancers, accounting for approximately 75% of all new cancer cases. Lung, liver, gastric, esophageal, colorectal, 
female breast, pancreatic, brain, and cervical cancers and leukemia were the leading causes of cancer death, account-
ing for approximately 80% of all cancer deaths. Cancer incidence, mortality, and spectrum were all different between 
urban and rural areas and between males and females.
Conclusions: The population covered by the cancer registries greatly increased from 2010 to 2011. The data quality 
and representativeness of cancer registries have gradually improved. Cancer registries have an irreplaceable role in 
research on cancer prevention and control. The disease burden of cancer is increasing, and the health department 
must implement effective measures to contain the increased cancer burden in China.
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Introduction
Cancer is a major public health issue in China. It is the 
second leading cause of death, and its incidence and mor-
tality continue to increase [1–3]. In 2008, the National 
Cancer Registration Program was launched by the Min-
istry of Health of China. Since then, the National Central 
Cancer Registry (NCCR) of China annually publishes 
cancer statistics based on the data reported by the cancer 
registries [4]. In this study, we analyzed the cancer inci-
dence and mortality in cancer registration areas in 2011 
and estimated the national numbers of new cancer cases 
and deaths to provide an overview of the current cancer 
statistics using data collected from local registries. The 
updated cancer burden results can be broadly used by the 
government, researchers, and clinicians for policy-mak-
ing and research.
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Methods
Data collection
A total of 234 cancer registries, located in 32 provinces, 
autonomous regions, and municipalities directly under 
the central government, submitted records of cancer 
new cases and deaths in 2011 to the NCCR. All data 
were evaluated based on the criteria of data quality of 
the NCCR. A total of 177 registries with qualified data 
were included in the final database for cancer statis-
tics analysis in 2011. The registries identified new can-
cer cases from all hospitals, community health centers, 
medical insurance databases, and death registries (for 
cases only identified by death certification). The regis-
tries obtained information on cancer deaths from the 
death surveillance system, which collects death infor-
mation from hospitals and the Civil Administration 
Bureau with available cremation records. Population 
information was collected from local statistical bureaus 
or household registry departments in local public secu-
rity bureaus.
Data quality control
The proportion of cases with morphologic verification 
(MV%), percentage of cancer cases identified by death 
certification only (DCO%), mortality to incidence (M/I) 
ratio, percentage of uncertified cancers (UB%), and 
percentage of cancers with undefined or unknown pri-
mary sites (secondary) (O&U%) were used to evaluate 
the completeness, validity, and reliability of the cancer 
statistics.
Statistical analysis
Pooled data were stratified by area (urban and rural), sex 
(males and females), age group (0, 1–4, 5–9, …, 80–84, 
85 years old and above), and cancer type. Cancer incident 
cases and deaths were estimated using age-specific rates, 
which were stratified by area, region (eastern, middle, 
western), cancer type, sex, and age. The 10 most common 
cancers in different groups were determined, and their 
proportions and cumulative rates were also calculated. 
The Chinese population census in 2000 and Segi’s pop-
ulation were used to determine age-standardized rates 
(ASRs) of incidence and mortality.
Results
Data sources
The 177 included cancer registries (77 in urban areas and 
100 in rural areas) covered a total of 175,310,169 persons 
(98,341,507 in urban areas and 76,968,662 in rural areas). 
The overall indicators of MV%, DCO%, and M/I ratio 
were 70.14%, 2.44%, and 0.63, respectively. They were 
72.92%, 2.17%, and 0.61 in urban registries and 65.34%, 
2.90%, and 0.67 in rural registries, respectively.
Incidences of all cancers
In 2011, 3,372,175 new cancer cases were estimated. 
The crude incidence in the Chinese cancer registration 
areas was 250.28/1,00,000 (277.77/1,00,000 for males 
and 221.37/1,00,000 for females), and the ASRs of inci-
dence by the Chinese standard population (ASRIC) 
and by the world standard population (ASRIW) were 
186.34/1,00,000 and 182.76/1,00,000, respectively, with 
a cumulative incidence (0–74  years old) of 21.20%. The 
crude incidence and ASRIC were 261.38/1,00,000 and 
189.89/1,00,000 in urban areas and 238.60/1,00,000 and 
182.10/1,00,000 in rural areas, respectively (Table  1). 
Cancer incidence was relatively lower in persons before 
age 39, increased dramatically after age 40, peaked after 
age 80, and then slightly decreased after age 85. This pat-
tern was similar between urban and rural areas.
Mortalities of all cancers
It was estimated that 2,113,048 persons died of cancer 
in 2011. The crude mortality in Chinese cancer regis-
tration areas was 156.83/1,00,000 (194.88/1,00,000 for 
males and 116.81/1,00,000 for females), and the ASRs of 
mortality by the Chinese standard population (ASRMC) 
and by the world standard population (ASRMW) were 
112.88/1,00,000 and 111.82/1,00,000, respectively, with 
a cumulative incidence of 12.69%. The crude mortality 
and ASRMC were 154.37/1,00,000 and 108.20/1,00,000 
in urban areas and 159.42/1,00,000 and 117.97/1,00,000 
in rural areas, respectively (Table 2). The cancer mortal-
ity was relatively lower in persons before age 45 and then 
dramatically increased, reaching its peak after age 85. The 
mortality in rural areas was the highest in the age 80–84 
group. The age-specific mortality of males was lower in 
urban areas than in rural areas in most age groups before 
age 80.
The 10 most common cancers in China
Lung cancer was the most common cancer in all areas, 
followed by female breast, gastric, liver, and colorectal 
cancers, with estimated new cases of 651,053, 248,620, 
420,489, 355,595, and 310,244 in 2011, respectively. 
Lung cancer was the most frequently diagnosed can-
cer in males, followed by gastric, liver, esophageal, and 
colorectal cancers; breast cancer was the most common 
cancer in females, followed by lung, colorectal, gastric, 
and liver cancers (Table  3). The 10 most common can-
cers accounted for approximately 75% of all cancer cases 
(Figure 1). In urban areas, lung cancer was the most fre-
quently diagnosed cancer (3,41,543 estimated new cases 
with an incidence of 49.44/1,00,000), followed by female 
breast, colorectal, gastric, and liver cancer; in rural areas, 
lung cancer was the most frequently diagnosed can-
cer (3,09,510 estimated new cases with an incidence of 
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47.14/1,00,000), followed by gastric, esophageal, liver, 
and colorectal cancers (Figures 2, 3).
Lung cancer was the leading cause of death in China, 
followed by liver, gastric, esophageal, and colorectal 
cancers, with estimated deaths of 529,153, 322,417, 
297,496, 218,957, and 149,722, respectively. In males, 
lung cancer was the leading cause of death, followed 
by liver, gastric, esophageal, and colorectal cancers; in 
Table 1 Cancer incidence in China in 2011
ASRIC age-standardized rate of incidence by the Chinese standard population in 2000, ASRIW age-standardized rate of incidence by the Segi’s world standard 
population.
Areas Sex Cancer cases Crude incidence (1/105) ASRIC (1/105) ASRIW (1/105) Cumulative rate (%)
All Both 3,372,175 250.28 186.34 182.76 21.20
Male 1,918,533 277.77 213.66 212.18 25.02
Female 1,453,642 221.37 161.47 155.84 17.43
Urban Both 1,805,624 261.38 189.89 185.75 21.28
Male 993,675 281.81 211.88 210.10 24.52
Female 811,949 240.09 170.79 164.35 18.22
Rural Both 1,566,551 238.60 182.10 179.24 21.08
Male 924,858 273.57 215.54 214.38 25.55
Female 641,693 201.49 150.57 146.02 16.51
Table 2 Cancer mortality in China in 2011
ASRMC age-standardized rate of mortality by the Chinese standard population in 2000, ASRMW age-standardized rate of mortality by the Segi’s world standard 
population.
Areas Sex Deaths Crude mortality (1/105) ASRMC (1/105) ASRMW (1/105) Cumulative rate (%)
All Both 2,113,048 156.83 112.88 111.82 12.69
Male 1,345,998 194.88 148.28 147.44 16.72
Female 767,050 116.81 79.42 78.31 8.67
Urban Both 1,066,408 154.37 108.20 107.14 11.79
Male 671,063 190.31 141.00 140.36 15.53
Female 395,345 116.90 77.42 76.14 8.15
Rural Both 1,046,640 159.42 117.97 116.84 13.65
Male 674,935 199.64 156.03 154.83 17.98
Female 371,705 116.71 81.66 80.71 9.22
Table 3 Ten cancers with the highest incidences in China, 2011
CNS central nervous system. Other abbreviations as in Table 1.
Rank Males Females












1 Lung 441,364 63.90 23.01 48.44 Breast 248,620 37.86 17.10 28.51
2 Stomach 296,419 42.92 15.45 32.62 Lung 209,689 31.93 14.43 21.93
3 Liver 264,635 38.32 13.79 29.30 Colorectum 131,840 20.08 9.07 14.02
4 Esophagus 205,560 29.76 10.71 22.47 Stomach 124,070 18.89 8.54 13.21
5 Colorectum 178,404 25.83 9.30 19.70 Liver 90,960 13.85 6.26 9.64
6 Bladder 53,074 7.68 2.77 5.82 Cervix 87,982 13.40 6.05 10.40
7 Prostate 49,007 7.10 2.55 5.33 Esophagus 85,678 13.05 5.89 8.85
8 Pancreas 45,385 6.57 2.37 4.99 Thyroid 67,788 10.32 4.66 8.70
9 Brain, CNS 43,289 6.27 2.26 5.22 Uterus 57,709 8.79 3.97 6.46
10 Lymphoma 41,298 5.98 2.15 4.80 Ovary 45,233 6.89 3.11 5.35
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Figure 1 Ten cancers with the highest incidences in urban areas of China, 2011.
Figure 2 Cancer incidences and mortalities in urban and rural areas 
for males in China, 2011 (1/1,00,000).
Figure 3 Cancer incidences and mortalities in urban and rural areas 
for females in China, 2011 (1/1,00,000).
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females, lung cancer was also the leading cause of death, 
followed by gastric, liver, esophageal, and colorectal can-
cers (Table 4). The top 10 leading causes of cancer death 
accounted for approximately 80% of all cancer deaths 
(Figure 4).
The cancer patterns were different between urban 
and rural areas and between males and females. The 
main cancers in rural areas were gastric and esopha-
geal cancers, followed by lung, liver, and colorectal 
cancers, whereas the main cancer in urban areas was 
lung cancer, followed by liver, gastric, and colorectal 
cancers.
Discussion
In 2014, there were 234 registries in China that submitted 
cancer registry data to the NCCR. The registered popula-
tions covered 16.4% of the Chinese population. Through 
double evaluations of data quality at the provincial and 
national levels, 177 registries were qualified for inclusion 
in the final pooled database, which was used for the eval-
uation of cancer statistics in 2011. For the cancer statis-
tics in 2010, the national population obtained by the sixth 
Population Census, which only examined the residential 
population, was used for the cancer statistics estimations 
[4]. However, the household population is considered 
Table 4 Ten cancers with the highest mortalities in China, 2011
Abbreviations as in Tables 2 and 3.
Rank Males Females












1 Lung 364,432 52.76 27.08 39.94 Lung 164,721 25.08 21.47 16.68
2 Liver 239,218 34.64 17.77 26.38 Stomach 90,792 13.83 11.84 9.21
3 Stomach 206,704 29.93 15.36 22.69 Liver 83,199 12.67 10.85 8.61
4 Esophagus 154,587 22.38 11.48 16.86 Esophagus 64,371 9.80 8.39 6.38
5 Colorectum 86,427 12.51 6.42 9.40 Colorectum 63,295 9.64 8.25 6.26
6 Pancreas 40,580 5.88 3.01 4.43 Breast 60,473 9.21 7.88 6.57
7 Brain, CNS 28,542 4.13 2.12 3.35 Pancreas 32,143 4.89 4.19 3.21
8 Leukemia 27,907 4.04 2.07 3.46 Cervix 23,375 3.56 3.05 2.59
9 Lymphoma 25,066 3.63 1.86 2.84 Brain, CNS 22,234 3.39 2.90 2.54
10 Bladder 20,949 3.03 1.56 2.23 Leukemia 19,708 3.00 2.57 2.45
Figure 4 Ten cancers with the highest mortalities in urban areas of China, 2011.
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more suitable for this analysis because cancer data are 
based on household registration.
The estimates of cancer incident cases and cancer 
deaths reasonably increased compared to those in previ-
ous years [5, 6], probably because of the aging population 
and the increasing trends of cancer incidence and mor-
tality. Urban areas in China had a higher cancer incidence 
and lower cancer mortality than rural areas, and the can-
cer patterns were quite different between urban and rural 
areas [2, 3]. A recent study showed that these differences 
were decreased [7, 8]. Lung cancer is now the most com-
mon cancer in rural areas instead of gastric cancer, and 
this may be due to the high prevalence of tobacco smok-
ing [9] and air pollution [10]. Liver cancer is still one of 
the most common cancers and one of the leading causes 
of cancer death in China [11, 12]. A current study showed 
that rural China had a lower 5-year relative survival rate 
than urban China [13, 14]. This disparity may be due to 
limited medical resources, the low number of cancer 
care centers and the greater number of patients with 
late-stage cancers in rural areas. The government should 
be aware of the differences in cancer statistics between 
urban and rural areas and implement effective measures 
to bridge the gap.
In 2014, extra funds were provided to the national pro-
gram to enhance follow-up and survival analyses, which 
are still lacking in most registries. The registration data 
should become more valuable and play an important 
role in cancer control. The National Cancer Center just 
started a Cancer Atlas Project, which will provide useful 
information about the geographic distribution of can-
cers to allow the National Cancer Control Program to be 
more efficient.
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